Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number With Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

Study Questions:

Are either of the new methods for assessing cardiovascular disease risk, of apolipoprotein B (apo B) or indirectly by nuclear magnetic resonance (NMR) spectroscopy of serum low-density lipoprotein particle number (LDL-P), superior for predicting cardiovascular disease (CVD) events?